Evaluation of the bioequivalence of two formulations containing the combination of 400 mg of acetaminophen (paracetamol), 4 mg of phenylephrine and 4 mg of chlorpheniramine in capsules: open-label, three-way crossover study, partially replicated in health. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 56, p. e17836 , 2020. DOI: 10.1590/s2175-97902020000217836. Disponível em: https://www.revistas.usp.br/bjps/article/view/181773.. Acesso em: 30 apr. 2024.